Novocure Ltd (NVCR) CEO Asaf Danziger Sold $6.6 million of Shares

CEO of Novocure Ltd (NASDAQ:NVCR) Asaf Danziger sold 227,304 shares of NVCR on 06/04/2018 at an average price of $29.09 a share. The total sale was $6.6 million.

NovoCure Ltd is a medical systems developer in the United States. Its primary product is the TTFields delivery system, which is a low-intensity therapy to combat acute tumors. NovoCure Ltd has a market cap of $2.87 billion; its shares were traded at around $31.65 with and P/S ratio of 14.53.

CEO Recent Trades:

CEO Asaf Danziger sold 227,304 shares of NVCR stock on 06/04/2018 at the average price of $29.09. The price of the stock has increased by 8.8% since.

CFO Recent Trades:

CFO Wilhelmus Cm Groenhuysen sold 30,470 shares of NVCR stock on 05/14/2018 at the average price of $30.04. The price of the stock has increased by 5.36% since.

Directors and Officers Recent Trades:

Chief Science Officer Eilon D. Kirson sold 346,161 shares of NVCR stock on 06/04/2018 at the average price of $28.9. The price of the stock has increased by 9.52% since.Director Charles G Phillips Iii sold 50,000 shares of NVCR stock on 05/25/2018 at the average price of $30.3. The price of the stock has increased by 4.46% since.Director Gabriel Leung sold 80,000 shares of NVCR stock on 05/16/2018 at the average price of $28.83. The price of the stock has increased by 9.78% since.

For the complete insider trading history of NVCR, click here

.